Stock Events

Fleury SA 

R$15.61
82
+R$0.22+1.43% Friday 20:07

Statistics

Day High
15.61
Day Low
15.31
52W High
18.96
52W Low
13.69
Volume
2,900,700
Avg. Volume
2,680,354
Mkt Cap
5.45B
P/E Ratio
13.91
Dividend Yield
0.95%
Dividend
0.15

Upcoming

Dividends

0.95%Dividend Yield
10Y Growth
-19.42%
5Y Growth
-14.72%
3Y Growth
-44.49%
1Y Growth
N/A

Earnings

9MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0.13
0.19
0.24
0.3
Expected EPS
0.298831438878
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FLRY3.SA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Danaher
DHR
Mkt Cap182.73B
Danaher Corporation operates in the diagnostics and research field, directly competing with Fleury SA's diagnostic services.
Quest Diagnostics
DGX
Mkt Cap16.01B
Quest Diagnostics is a provider of diagnostic information services, similar to Fleury SA, making it a direct competitor in the healthcare diagnostics market.
Labcorp
LH
Mkt Cap0
Laboratory Corporation of America Holdings operates in the same clinical laboratory services sector as Fleury SA, offering similar diagnostic and testing services.
Bio-Rad Laboratories
BIO
Mkt Cap8.57B
Bio-Rad Laboratories, Inc. provides clinical diagnostics and life science research products, competing in the diagnostics segment alongside Fleury SA.
Thermo Fisher Scientific
TMO
Mkt Cap209.21B
Thermo Fisher Scientific Inc. offers products and services in the diagnostics field, competing with Fleury SA in the healthcare diagnostics and research market.
Agilent Technologies
A
Mkt Cap38.58B
Agilent Technologies, Inc. provides instruments, services, consumables, applications, and expertise in the diagnostics and research field, competing with Fleury SA.
Bruker
BRKR
Mkt Cap9.41B
Bruker Corporation offers scientific instruments and diagnostic solutions, competing in the same market as Fleury SA.
Waters
WAT
Mkt Cap17.94B
Waters Corporation produces analytical standards and instruments, including for the healthcare industry, competing with Fleury SA in the diagnostics market.
Resmed
RMD
Mkt Cap30.09B
ResMed Inc. specializes in cloud-connectable medical devices for sleep apnea, COPD, and other chronic diseases, indirectly competing with Fleury SA in the broader healthcare diagnostics and treatment market.

About

Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and image exam, diagnostic information, check-up and reference laboratory, genomics, clinic day, center of infusions, dental imaging exam, dental radiology, and diagnostic imaging services. The company also offers Saúde I, a digital healthcare platform that provides services, including teleconsultations, medical, diagnostic medicine exams, and procedures; and corporate solutions and face-to-face primary care, as well as solutions for physicians with digital office and medical education. It operates 284 customer service units and 31 hospital-based units under the Labs a+, Felippe Mattoso, Lafe, Fleury, a+SP, CIP, Moacir Cunha, Vita, inlab, Weinmann, Serdil, a+ and Diagmax, a+, IRN / CPC, Diagnosis a+, a+BA, and Pretti and Bioclinic brand names. The company was founded in 1926 and is headquartered in São Paulo, Brazil.
Show more...
CEO
Ms. Jeane Mike Tsutsui
Employees
16700
Country
Brazil
ISIN
BRFLRYACNOR5

Listings